Last update 01 Nov 2024
Agna Biopharmaceutical Co., Ltd.
Private Company|
2021|
Guangdong Sheng, China
Last update 01 Nov 2024
Overview
Basic Info
Introduction Founded in 2020, Argorna Pharmaceuticals Ltd. is an RNA innovative drug company co-founded by RNAi discoverers, 2006 Nobel Prize winners and senior overseas scientists. The company has an experienced RNA drug research and development team, RNA drug research and development platform and large-scale mRNA vaccine production line, and has a number of invention patents in the field of RNA. The company has independent intellectual property rights of GalPET liver targeting RNAi and lipid nanoparticle (LNP) delivery core platform technology. In March 2022, Phase II clinical trials of the COVID-19 mRNA vaccine developed by Argorna Pharmaceuticals Ltd. and Guangzhou Ribobio Co., Ltd. |
Tags
Respiratory Diseases
Infectious Diseases
mRNA vaccine
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Vaccine (RBMRNA-405) as a Booster in Chinese Adults & Older
A Phase I/II, Randomized, Blind, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (RBMRNA-176) in Healthy Adults Aged 18 Years and Older
100 Clinical Results associated with Agna Biopharmaceutical Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Agna Biopharmaceutical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Agna Biopharmaceutical Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 23 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
1
Phase 2 Clinical
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free